Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2025
Pharma News, 2025
FDA Approves Merilog
FDA Approves Merilog as Biosimilar to Insulin Aspart for Diabetes
Robert F. Kennedy Jr Confirmed as HHS Secretary
Robert F. Kennedy Jr Confirmed as HHS Secretary, Nearly Along Party Lines
US Government
US Government actions having a serious impact on global health, WHO chief says
InfectoPharm Invests in AudioCure
InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy
Conduit taps Charles River
Conduit taps Charles River to build preclinical autoimmune case for AstraZeneca diabetes asset
Aardvark prices $94.2m IPO
Aardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drug
Novartis bolsters
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
FDA Grants Priority
FDA Grants Priority Review to Brensocatib for Treatment of Bronchiectasis
Arrowhead Pharmaceuticals Announces Closing of Global License
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
Lilly Sells $6.5 Billion
Lilly Sells $6.5 Billion of Bonds for Cancer Drug Purchase
Palisade Bio Presents
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
US FDA approves AbbVie-Pfizer
US FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections
44
45
46
47
48
49
50
51
52